Published in Hypertension on August 15, 2016
Carotid Body Removal for the Treatment of Resistant Hypertension | NCT01745172
Autonomic Nervous System and Nitric Oxide Interactions | NCT01137253
The effects of different physical activities on atrial fibrillation in patients with hypertension and chronic kidney disease. Kidney Res Clin Pract (2017) 0.75
The Role of the Autonomic Nervous System in the Pathophysiology of Obesity. Front Physiol (2017) 0.75
Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest (1996) 4.98
Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest (1994) 3.49
Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab (1999) 3.26
The carotid body as a therapeutic target for the treatment of sympathetically mediated diseases. Hypertension (2012) 3.07
Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation (1998) 2.04
The sympathetic nervous system in hypertension: assessment by blood pressure variability and ganglionic blockade. J Hypertens (2003) 1.98
Contribution of endothelial nitric oxide to blood pressure in humans. Hypertension (2006) 1.85
Clinical research subject recruitment: the Volunteer for Vanderbilt Research Program www.volunteer.mc.vanderbilt.edu. J Am Med Inform Assoc (2005) 1.76
Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C. Diabetes (2001) 1.76
Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation. J Am Coll Cardiol (2002) 1.68
Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation (1997) 1.60
Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans. Int J Obes Relat Metab Disord (2002) 1.54
Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int J Obes Relat Metab Disord (1999) 1.45
Neural mechanisms in human obesity-related hypertension. J Hypertens (1999) 1.30
Sympathetically mediated hypertension in autonomic failure. Circulation (2000) 1.29
Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J Clin Invest (1994) 1.28
The hypertension of autonomic failure and its treatment. Hypertension (1997) 1.18
Increased vascular beta2-adrenoceptor responsiveness in autonomic dysfunction. J Am Coll Cardiol (1984) 1.13
Mitochondrial production of reactive oxygen species contributes to the β-adrenergic stimulation of mouse cardiomycytes. J Physiol (2011) 1.13
Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain. J Clin Invest (1993) 1.12
Ethnic differences in insulinemia and sympathetic tone as links between obesity and blood pressure. Hypertension (2000) 1.04
Excessive nitric oxide function and blood pressure regulation in patients with autonomic failure. Hypertension (2008) 1.02
Blockade of nucleoside transport is required for delivery of intraarterial adenosine into the interstitium: relevance to therapeutic preconditioning in humans. Circulation (2003) 0.95
Endothelium-dependent relaxation of small arteries from essential hypertensive patients: mechanisms and comparison with normotensive subjects and with responses of vessels from spontaneously hypertensive rats. Clin Sci (Lond) (1995) 0.94
Sympathetic activation and nitric oxide function in early hypertension. Am J Physiol Heart Circ Physiol (2012) 0.93
The potent pressor effect of phenylpropanolamine in patients with autonomic impairment. JAMA (1987) 0.86
Autonomic blockade improves insulin sensitivity in obese subjects. Hypertension (2014) 0.85
Sympathetic nerve activity and peripheral vasodilator capacity in young and older men. Am J Physiol Heart Circ Physiol (2014) 0.85
The effect of moxonidine on endothelial dysfunction in metabolic syndrome. Am J Cardiovasc Drugs (2006) 0.84
Role of adenosine and nitric oxide on the mechanisms of action of dipyridamole. Stroke (2005) 0.83
Enhanced contraction to noradrenaline, serotonin and nerve stimulation but normal endothelium-derived relaxing factor response in skin small arteries in human primary hypertension. Clin Exp Pharmacol Physiol Suppl (1992) 0.82
Does sympathetic activation blunt nitric oxide-mediated hyperemia in the human forearm? Clin Auton Res (1997) 0.81
Decreased endothelial nitric oxide, systemic oxidative stress, and increased sympathetic modulation contribute to hypertension in obese rats. Am J Physiol Heart Circ Physiol (2014) 0.81
Hypothalamic-pituitary-adrenal axis and sympathetic nervous system activities in Pima Indians and Caucasians. Metabolism (1999) 0.79
Effects of trimethaphan on arterial blood histamine and systemic hemodynamics in humans. Anesthesiology (1985) 0.78
Contraindication to the use of ocular phenylephrine in idiopathic orthostatic hypotension. Am J Ophthalmol (1979) 0.77